Cytochrome P450-mediated metabolism in brain: Functional roles and their implications

Expert Opinion on Drug Metabolism and Toxicology

Volumn 9, Issue 5, 2013, Pages 551-558

  Ravindranath, Vijayalakshmi ^a   Strobel, Henry W ^b  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

CNS; Drug metabolism; Inflammation; Leukotrienes; Psychoactive drugs

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTITUSSIVE AGENT; ARIPIPRAZOLE; CENTRAL STIMULANT AGENT; CITALOPRAM; CLOMIPRAMINE; CODEINE; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2B; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; CYTOCHROME P450 4F11; DEXTROMETHORPHAN; ETHYLMORPHINE; HALOPERIDOL; LEUKOTRIENE; METHADONE; NEUROLEPTIC AGENT; OPIATE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE; XENOBIOTIC AGENT;

ALTERNATIVE RNA SPLICING; BRAIN METABOLISM; DRUG METABOLISM; DRUG TRANSFORMATION; HUMAN; INFLAMMATION; LIVER METABOLISM; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

ALTERNATIVE SPLICING; ARACHIDONIC ACID; BIOTRANSFORMATION; BRAIN; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; GENE EXPRESSION; HUMANS; LIVER; MIXED FUNCTION OXYGENASES; PROSTAGLANDINS; XENOBIOTICS;

EID: 84876379067     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.2013.759208     Document Type: Review

References (50)

1. Halpert JR, Domanski TL, Adali O, et al. Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolism. Drug Metab Dispos 1998;26(12):1223-31
2. Nelson DR, Kamataki T, Waxman DJ, et al. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 1993;12(1):1-51 k; 2005
3. Eichelbaum M, Burk O. CYP3A genetics in drug metabolism. Nat Med 2001;7(3):285-7
4. Chinta SJ, Kommaddi RP, Turman CM, et al. Constitutive expression and localization of cytochrome P-450 1A1 in rat and human brain: presence of a splice variant form in human brain. J Neurochem 2005;93(3):724-36
5. Imig JD, Simpkins AN, Renic M, Harder DR. Cytochrome P450 eicosanoids and cerebral vascular function. Expert Rev Mol Med 2011;13:e7
6. Kalsotra A, Strobel HW. Cytochrome P450 4F subfamily: at the crossroads of eicosanoid and drug metabolism. Pharmacol Ther 2006;112(3):589-611
7. Machala M, Soucek P, Neca J, et al. Inter-species comparisons of hepatic cytochrome P450 enzyme levels in male ruminants. Arch Toxicol 2003;77(10):555-60
8. Dong D, Wu B. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling. Drug Metab Rev 2012;44(1):1-17 1
9. Otyepka M, Berka K, Anzenbacher P. Is there a relationship between the substrate preferences and structural flexibility of cytochromes P450? Curr Drug Metab 2012;13(2):130-42 1
10. Pavek P, Dvorak Z. Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr DrugMetab 2008;9(2):129-43 1
11. Agarwal V, Kommaddi RP, Valli K, et al. Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metabolite. PLoS One 2008;3(6):e2337 1
12. Pai HV, Kommaddi RP, Chinta SJ, et al. A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502D7 that demethylates codeine to morphine. J Biol Chem 2004;279(26):27383-9 1
13. Boyd MR. Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung. Nature 1977;269(5630):713-15 1
14. Dutheil F, Jacob A, Dauchy S, et al. ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders. Expert Opin Drug Metab Toxicol 2010;6(10):1161-74 1
15. Ghersi-Egea JF, Monkkonen KS, Schmitt C, et al. Blood-brain interfaces and cerebral drug bioavailability. Rev Neurol (Paris) 2009;165(12):1029-38 1
16. Sasame HA, Ames MM, Nelson SD. Cytochrome P-450 and NADPH cytochrome c reductase in rat brain: formation of catechols and reactive catechol metabolites. Biochem Biophys Res Commun 1977;78(3):919-26 1
17. Kawashima H, Strobel HW. cDNA cloning of three new forms of rat brain cytochrome P450 belonging to the CYP4F subfamily. Biochem Biophys Res Commun 1995;217(3):1137-44 2
18. Anandatheerthavarada HK, Shankar SK, Bhamre S, et al. Induction of brain cytochrome P-450IIE1 by chronic ethanol treatment. Brain Res 1993;601(1-2):279-85 2
19. Ravindranath V, Anandatheerthavarada HK, Shankar SK. NADPH cytochrome P-450 reductase in rat, mouse and human brain. Biochem Pharmacol 1990;39(6):1013-18 2
20. Ravindranath V, Anandatheerthavarada HK, Shankar SK. Xenobiotic metabolism in human brain-presence of cytochrome P-450 and associated mono-oxygenases. Brain Res 1989;496(1-2):331-5 2
21. Chinta SJ, Pai HV, Upadhya SC, et al. Constitutive expression and localization of the major drug metabolizing enzyme, cytochrome P4502D in human brain. Brain Res Mol Brain Res 2002;103(1-2):49-61 2
22. Upadhya SC, Tirumalai PS, Boyd MR, et al. Cytochrome P4502E (CYP2E) in brain: constitutive expression, induction by ethanol and localization by fluorescence in situ hybridization. Arch Biochem Biophys 2000;373(1):23-34 2
23. Pai HV, Upadhya SC, Chinta SJ, et al. Differential metabolism of alprazolam by liver and brain cytochrome (P4503A) to pharmacologically active metabolite. Pharmacogenomics J 2002;2(4):243-58 2
24. Bhamre S, Anandatheerathavarada HK, Shankar SK, et al. Purification of multiple forms of cytochrome P450 from a human brain and reconstitution of catalytic activities. Arch Biochem Biophys 1993;301(2):251-5 2
25. Bhamre S, Anandatheerthavarada HK, Shankar SK, Ravindranath V. Microsomal cytochrome P450 in human brain regions. Biochem Pharmacol 1992;44(6):1223-5 2
26. Ferguson CS, Tyndale RF. Cytochrome P450 enzymes in the brain: emerging evidence of biological significance. Trends Pharmacol Sci 2011;32(12):708-14 2
27. Anandatheerthavarada HK, Boyd MR, Ravindranath V. Characterization of a phenobarbital-inducible cytochrome P-450, NADPH-cytochrome P- 450 reductase and reconstituted cytochrome P-450 mono-oxygenase system from rat brain. Evidence for constitutive presence in rat and human brain. Biochem J 1992;288(Pt 2):483-8 3
28. Kommaddi RP, Turman CM, Moorthy B, et al. An alternatively spliced cytochrome P4501A1 in human brain fails to bioactivate polycyclic aromatic hydrocarbons to DNA-reactive metabolites. J Neurochem 2007;102(3):867-77 3
29. Bhagwat SV, Leelavathi BC, Shankar SK, et al. Cytochrome P450 and associated monooxygenase activities in the rat and human spinal cord: induction, immunological characterization and immunocytochemical localization. Neuroscience 1995;68(2):593-601 3
30. McFayden MC, Melvin WT, Murray GI. Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain. Biochem Pharmacol 1998;55(6):825-30 3
31. Anzenbacher P, Anzenbacherova E. Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 2001;58(5-6):737-47 3
32. Miksys S, Rao Y, Hoffmann E, et al. Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics. J Neurochem 2002;82(6):1376-87 3
33. Hipolito L, Sanchez MJ, Polache A, Granero L. Brain metabolism of ethanol and alcoholism: an update. Curr Drug Metab 2007;8(7):716-27 3
34. Song BJ. Ethanol-inducible cytochrome P450 (CYP2E1): biochemistry, molecular biology and clinical relevance: 1996 update. Alcohol Clin Exp Res 1996;20(8 Suppl):138A-46A 3
35. Watts PM, Riedl AG, Douek DC, et al. Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase. Neuroscience 1998;86(2):511-19 3
36. Grabowski PJ, Black DL. Alternative RNA splicing in the nervous system. Prog Neurobiol 2001;65(3):289-308 3
37. Turman CM, Hatley JM, Ryder DJ, et al. Alternative splicing within the human cytochrome P450 superfamily with an emphasis on the brain: the convolution continues. Expert Opin Drug Metab Toxicol 2006;2(3):399-418 4
38. Cojocaru V, Winn PJ, Wade RC. Multiple, ligand-dependent routes from the active site of cytochrome P450 2C9. Curr Drug Metab 2012;13(2):143-54 4
39. Kalsotra A, Anakk S, Boehme CL, Strobel HW. Sexual dimorphism and tissue specificity in the expression of CYP4F forms in Sprague Dawley rats. Drug Metab Dispos 2002;30(9):1022-8 4
40. Kikuta Y, Kusunose E, Kusunose M. Characterization of human liver leukotriene B(4) omega-hydroxylase P450 (CYP4F2). J Biochem 2000;127(6):1047-52 4
41. Stark K, Torma H, Cristea M, Oliw EH. Expression of CYP4F8 (prostaglandin H 19-hydroxylase) in human epithelia and prominent induction in epidermis of psoriatic lesions. Arch Biochem Biophys 2003;409(1):188-96 4
42. Cui X, Nelson DR, Strobel HW. A novel human cytochrome P450 4F isoform (CYP4F11): cDNA cloning, expression, and genomic structural characterization. Genomics 2000;68(2):161-6 4
43. Bylund J, Bylund M, Oliw EH. cDna cloning and expression of CYP4F12, a novel human cytochrome P450. Biochem Biophys Res Commun 2001;280(3):892-7 4
44. Hashizume T, Imaoka S, Hiroi T, et al. cDNA cloning and expression of a novel cytochrome p450 (cyp4f12) from human small intestine. Biochem Biophys Res Commun 2001;280(4):1135-41 4
45. Stark K, Schauer L, Sahlen GE, et al. Expression of CYP4F12 in gastrointestinal and urogenital epithelia. Basic Clin Pharmacol Toxicol 2004;94(4):177-83 4
46. Lefevre C, Bouadjar B, Ferrand V, et al. Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3. Hum Mol Genet 2006;15(5):767-76 4
47. Sehgal N, Agarwal V, Valli RK, et al. Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation. Biochem Pharmacol 2011;82(1):53-64 5
48. Kikuta Y, Kusunose E, Endo K, et al. A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes. cDNA cloning and expression of leukotriene B4 omega-hydroxylase. J Biol Chem 1993;268(13):9376-80 5
49. Kalsotra A, Turman CM, Kikuta Y, Strobel HW. Expression and characterization of human cytochrome P450 4F11: putative role in the metabolism of therapeutic drugs and eicosanoids. Toxicol Appl Pharmacol 2004;199(3):295-304 5
50. Sehgal N, Kumawat KL, Basu A, Ravindranath V. Fenofibrate reduces mortality and precludes neurological deficits in survivors in murine model of Japanese encephalitis viral infection. PloS One 2012;7(4):e35427